Previous 10 | Next 10 |
home / stock / myco:cc / myco:cc news
Prior studies have found that psychedelic substances can alter states of consciousness . However, until now it was unknown which receptors played a role in this change. New research conducted by a group of scientists from various institutions has demonstrated how a drug-induced change in an...
Last week, the joint Public Health Committee in Connecticut passed a measure that would allow the state to offer eligible patients access to psychedelic-assisted treatment . The bill, HB 5396, was approved on a noncontroversial basis and will be advancing to the floor for consideration. T...
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) , a biotechnology company aiming to transform the treatment of mental health and addiction disorders, has received conditional approval from the Institutional Review Board ("IRB") for its planned multisite phase 2b smoking cessa...
DENVER, March 24, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), a biotechnology company aiming to transform the treatment of mental health and addiction disorders, today announced ...
While almost every individual will experience a traumatic event at least once in their lifetime, not everybody will develop post-traumatic stress disorder (“PTSD”). Research has found that unlike the general population, some groups do undergo experiences that make them more s...
We recently saw Russia invade Ukraine, which prompted millions of Ukrainians to flee their homes as the war intensified. Disturbing videos and photos of the damage done to buildings and people in cities such as Kharkov and Kyiv can be accessed online, even by those thousands of miles away....
Various companies and experts are hailing psychedelics such as MDMA, LSD and psilocybin, as well as mind-altering substances such as ketamine, as the next revolutionary treatment for a number of mental health conditions. The surge in the popularity of psychedelic substances started alm...
Mydecine participated in this year’s Annual Roth Conference, the Oppenheimer & Co. Annual Healthcare Conference, and will be at the upcoming Maxim Group’s Virtual Growth Conference These conferences represent an opportunity for the company to share its R&D pipeline...
Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) , a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, is among organizations, working alongside researchers at the center of the veritable renaissance of psychedelics. &...
New research on addiction conducted by scientists from the University of California-Irvine has discovered links between metabolism and the circadian rhythm. The circadian clock relies on various interactions between systems to maintain regular timing and is entwined with... Read more ...
News, Short Squeeze, Breakout and More Instantly...
MYDECINE INNOVATIONS GROUP INC. Company Name:
MYCO:CC Stock Symbol:
AQNC Market:
MYDECINE INNOVATIONS GROUP INC. Website:
A look at the top 10 most actives in Canada Canadian Natural Resources Limited (CNQ) rose 1.6% to $49.86 on volume of 16,918,783 shares Cenovus Energy Inc. (CVE) rose 1.2% to $27.09 on volume of 11,032,869 shares Toronto-Dominion Bank (The) (TD) rose 1.0% to $76.74 on volume of 10,871,605...
A look at the top 10 most actives in Canada Toronto-Dominion Bank (The) (TD) rose 0.3% to $76.13 on volume of 16,847,005 shares Canadian Natural Resources Limited (CNQ) fell 1.5% to $48.33 on volume of 7,922,140 shares TC Energy Corporation (TRP) rose 0.1% to $51.11 on volume of 7,293,869...
(TheNewswire) Vancouver, British Columbia, July 5, 2024— TheNewswire – Mydecine Innovations Group Inc. (the “ Company ”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) is pleased to confirm that further to its news release dated June 13, 2024, ...